In response to: K. Vijayalakshmi, et al, vol. 16, no. 12, pp. 707-711: A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
Pinès
Emmanuelle
E
Zamia
Philippe
P
Idée
Jean-Marc
JM
D006328:Cardiac Catheterization / Q000379:methods; D003287:Contrast Media / Q000008:administration & dosage* / Q000009:adverse effects*; D004311:Double-Blind Method; D004562:Electrocardiography; D006801:Humans; D015994:Incidence; D007472:Iohexol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D007479:Iopamidol / Q000008:administration & dosage* / Q000009:adverse effects*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D014693:Ventricular Fibrillation / Q000175:diagnosis / Q000453:epidemiology
D003287:Contrast Media; C093233:iobitridol; D007472:Iohexol; D007479:Iopamidol